Report of the Clinical Protocol Committee: Development of Randomized Trials for Malignant Bowel Obstruction

Feuer, 2004, Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer, Vol. 4

Ripamonti, 2002, Palliative management of malignant bowel obstruction, Int J Gynecol Cancer, 12, 135, 10.1046/j.1525-1438.2002.01103.x

Ketcham, 1970, Delayed intestinal obstruction following treatment for cancer, Cancer, 25, 406, 10.1002/1097-0142(197002)25:2<406::AID-CNCR2820250219>3.0.CO;2-4

Osteen, 1980, Malignant intestinal obstruction, Surgery, 87, 611

Legendre, 2001, Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction, Eur J Surg Oncol, 27, 364, 10.1053/ejso.2001.1120

Maglinte, 2003, Current concepts in imaging of small bowel obstruction, Radiol Clin North Am, 41, 263, 10.1016/S0033-8389(02)00114-8

Delabrousse, 2003, CT of small bowel obstruction in adults, Abdom Imaging, 28, 257, 10.1007/s00261-002-0016-4

Low, 2003, Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MR imaging, Radiology, 228, 157, 10.1148/radiol.2281020728

Bastounis, 1989, Somatostatin as adjuvant therapy in the management of obstructive ileus, Hepatogastroenterology, 36, 538

Mercadante, 1996, Octreotide prevents the pathological laterations of bowel obstruction in cancer patients, Support Care Cancer, 4, 393, 10.1007/BF01788848

Krouse, 2004, Surgical management of malignant bowel obstruction, Surg Oncol Clin N Am, 13, 479, 10.1016/j.soc.2004.03.006

Cannizzaro, 1995, Percutaneous endoscopic gastrostomy as a decompressive technique in bowel obstruction due to abdominal carcinomatosis, Endoscopy, 27, 317, 10.1055/s-2007-1005700

Cunningham, 1995, Percutaneous gastrostomy for decompression in patients with advanced gynecologic malignancies, Gynecol Oncol, 59, 273, 10.1006/gyno.1995.0021

Higashi, 2003, Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer, Jpn J Clin Onc, 33, 357, 10.1093/jjco/hyg061

Yazdi, 1996, High mortality after abdominal operation in patients with large-volume malignant ascites, J Surg Oncol, 62, 93, 10.1002/(SICI)1096-9098(199606)62:2<93::AID-JSO4>3.0.CO;2-L

Turnbull, 1989, Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin, J Clin Oncol, 7, 381, 10.1200/JCO.1989.7.3.381

Lund, 1989, Intestinal obstruction in patients with advanced carcinoma of the ovaries treated with combination chemotherapy, Surg Gynecol Obstet, 169, 213

Solomon, 1983, Complications in the management of ovarian cancer, Aust N Z J Obstet Gynaecol, 23, 65, 10.1111/j.1479-828X.1983.tb00165.x

Phillip, 1997, Outcomes in patients with GIT obstruction—62 episodes in 33 patients in a 12 month period, Int J Gynecol Cancer, 7, 86

Baines, 1985, Medical management of intestinal obstruction in patients with advanced malignant disease, Lancet, 2, 990, 10.1016/S0140-6736(85)90534-3

Ripamonti, 2001, Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Working Group of the European Assiciation for Palliative Care, Support Care Cancer, 9, 223, 10.1007/s005200000198

Ripamonti, 2000, Role of octreotide, scopolamine butylbromide and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial, J Pain Symptom Manage, 19, 23, 10.1016/S0885-3924(99)00147-5

Glare, 2004, Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer, Support Care Cancer, 12, 432, 10.1007/s00520-004-0629-y

Feuer, 2004, Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer, Vol. 4

Basson, 1989, Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction?, Am J Surg, 157, 109, 10.1016/0002-9610(89)90429-7

Neville, 1991, Vascular responsiveness in obstructed gut, Dis Colon Rectum, 34, 229, 10.1007/BF02090162

Ripamonte, 2004, How to use octreotide for malignant bowel obstruction, J Support Oncol, 2, 1

Mercadante, 1992, Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients, J Pain Symptom Manage, 7, 496, 10.1016/0885-3924(92)90137-7

Khoo, 1992, Control of emesis in bowel obstruction in terminally ill patients, Lancet, 339, 375, 10.1016/0140-6736(92)91700-I

Steadman, 1996, A woman with malignant bowel obstruction who did not want to die with tubes, Lancet, 347, 944, 10.1016/S0140-6736(96)91418-X

Mercadante, 2000, Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction, Support Care Cancer, 8, 188, 10.1007/s005200050283

Mystakidou, 2002, Comparison of octreotide administration vs. conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial, Anticancer Res, 22, 1187

Khot, 2002, Systematic review of the efficacy and safety of colorectal stents, Br J Surg, 89, 1096, 10.1046/j.1365-2168.2002.02148.x

Sebastian, 2004, Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction, Am J Gastroenterol, 99, 2051, 10.1111/j.1572-0241.2004.40017.x